Your browser doesn't support javascript.
loading
Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment.
Weersink, Rianne A; Timmermans, Lotte; Monster-Simons, Margje H; Mol, Peter G M; Metselaar, Herold J; Borgsteede, Sander D; Taxis, Katja.
Affiliation
  • Weersink RA; Unit of Pharmacotherapy, Epidemiology & Economics, Department of Pharmacy, University of Groningen, Groningen, Netherlands.
  • Timmermans L; Department of Clinical Decision Support, Health Base Foundation, Houten, Netherlands.
  • Monster-Simons MH; Unit of Pharmacotherapy, Epidemiology & Economics, Department of Pharmacy, University of Groningen, Groningen, Netherlands.
  • Mol PGM; Department of Pharmaceutical and Pharmacological Sciences, Unit of Clinical Pharmacology and Pharmacotherapy, Catholic University of Leuven, Leuven, Belgium.
  • Metselaar HJ; Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, Netherlands.
  • Borgsteede SD; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands.
  • Taxis K; Dutch Medicines Evaluation Board (CBG-MEB), Utrecht, Netherlands.
Front Pharmacol ; 10: 1031, 2019.
Article in En | MEDLINE | ID: mdl-31607904
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Front Pharmacol Year: 2019 Document type: Article Affiliation country: Netherlands Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Front Pharmacol Year: 2019 Document type: Article Affiliation country: Netherlands Country of publication: Switzerland